In the July edition of Pharma Bio World, Dr Manjul Joshipura, Senior Vice President, Innovations and New Product Development, Cadila Pharmaceuticals talks about how India has made a lot of progress in the formulations industry and yet we still have a long way to go when it comes to the API industry. However, with Make in India initiative, it is a significant opportunity for the pharma industry to make a mark in the pharmaceutical world. Read the excerpt of the interview here:
“The concept of Make in India & Cadila Pharmaceuticals goes hand in hand. We were one of the 1st Indian companies to establish a manufacturing unit. Given the right ecosystem and right incentive, this will be a huge opportunity that Indian pharma industry can benefit on.”
Watch the complete video here:
